Unbiased AI-powered news
1 stories related to this topic, newest first.
U.S. senators are reviving a proposal to extend the $35 insulin price cap beyond Medicare to the private market and uninsured patients. The measure is modeled on a 2022 law that already limits costs for Medicare beneficiaries.